Filing Flows › Comparisons › NMTC vs NSPR
Neuroone Medical Technologies vs InspireMD: NMTC and NSPR compared
Neuroone Medical Technologies is the larger company: $2.0M of revenue in its latest quarter (Q3 FY26) against $1.8M for InspireMD (Q2 2026). Neuroone Medical Technologies is growing faster (+16% against -0.4% a year earlier). Neuroone Medical Technologies is more profitable, with an operating margin of -122.9% against -815.6%.
Where the money goes: NMTC and NSPR
Neuroone Medical Technologies (NMTC) · Q3 FY26
Neuroone Medical Technologies, Q3 FY26: revenue $2.0M (+16% year over year), operating margin -122.9%, net loss $2.0M, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
InspireMD (NSPR) · Q2 2026
InspireMD, Q2 2026: revenue $1.8M (-0.4% year over year), operating margin -815.6%, net loss $14.3M, operating cash flow −$10.9M. The chart follows the revenue to costs, profit and cash.
| Neuroone Medical Technologies (NMTC) | InspireMD (NSPR) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q2 2026 |
| Revenue | $2.0M | $1.8M |
| Revenue growth, Y/Y | +16% | -0.4% |
| Operating margin | -122.9% | -815.6% |
| Net earnings | −$2.0M | −$14.3M |
| Net margin | -101.7% | -808.8% |
| Operating cash flow | −$1.1M | −$10.9M |
Questions
Which is bigger, Neuroone Medical Technologies or InspireMD?
Neuroone Medical Technologies is the larger company: $2.0M of revenue in its latest quarter (Q3 FY26) against $1.8M for InspireMD (Q2 2026).
Is Neuroone Medical Technologies or InspireMD growing faster?
Neuroone Medical Technologies is growing faster (+16% against -0.4% a year earlier).
Which is more profitable, Neuroone Medical Technologies or InspireMD?
Neuroone Medical Technologies is more profitable, with an operating margin of -122.9% against -815.6%.
More: Neuroone Medical Technologies earnings · how Neuroone Medical Technologies makes money · InspireMD earnings · how InspireMD makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.